Arsenic trioxide and all-trans retinoic acid combination therapy for the treatment of high-risk acute promyelocytic leukemia: results from the APOLLO trial : hematologic malignancy - Platzbecker, Uwe; Adès, Lionel; Montesinos, Pau; Ammatuna, Emanuele; Fenaux, Pierre; Baldus, Claudia; Bernardi, Massimo; Berthon, Céline; Bocchia, Monica; Bonmati, Caroline; Borlenghi, Erika; Bornhäuser, Martin; et al. (Journal of clinical oncology, 2025)
Mitglieder der SAL, AMCL-CG, AML-SG, OSHO, PETHEMA, HOVON, AND GIMEMA STUDY GROUPS: Fatiha Chermat (Groupe Francophone des My´elodysplasies (GFM), Hopital Saint Louis; Service d’Hematologie S´eniors, Paris, France); Livia Gorreo Renzulli, MSc(Fondazione GIMEMA Franco Mandelli Onlus, Roma, Italy); Madlen Jentzsch, MD (University Hospital Leipzig, Department for Hematology, Cellular Therapy and Hemostaseology, Leipzig, Germany); Dietger Niederwieser, MD (University Hospital Leipzig, Department for Hematology, Cellular Therapy and Hemostaseology, Leipzig, Germany); Michaela Weier (TUD Dresden University of Technology - Faculty of Medicine Carl Gustav Carus, Medical Clinic I, Dresden, Germany); Sven Zukunft, PhD (TUD Dresden University of Technology - Faculty of Medicine Carl Gustav Carus, Medical Clinic I, Dresden, Germany)